|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.94(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,003,203 |
52
Week Range: |
$38.26 - $89.25 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bryant Douglas C |
President & CEO |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,204 |
430,217 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2020-02-10 |
4 |
D |
$77.52 |
$23,334 |
D/D |
(301) |
9,738 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
735 |
10,039 |
|
- |
|
Bujarski Robert Joseph |
SVP, NA Comm Ops & Gen Counsel |
|
2020-02-10 |
4 |
D |
$77.52 |
$37,985 |
D/D |
(490) |
30,396 |
|
- |
|
Bujarski Robert Joseph |
SVP, NA Comm Ops & Gen Counsel |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
30,886 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
20,794 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2020-02-10 |
4 |
D |
$77.52 |
$51,861 |
D/D |
(669) |
4,327 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
4,996 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2020-01-07 |
4 |
OE |
$21.07 |
$190,494 |
D/D |
9,041 |
28,584 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-12-06 |
4 |
S |
$70.00 |
$778,540 |
D/D |
(11,122) |
9,304 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-12-06 |
4 |
OE |
$15.40 |
$174,226 |
D/D |
11,122 |
20,426 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-12-05 |
4 |
S |
$70.00 |
$329,000 |
D/D |
(4,700) |
9,304 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-12-05 |
4 |
OE |
$23.41 |
$110,027 |
D/D |
4,700 |
14,004 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-12-03 |
4 |
S |
$68.01 |
$1,561,078 |
D/D |
(22,951) |
3,795 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-12-03 |
4 |
OE |
$22.85 |
$151,267 |
D/D |
6,620 |
23,389 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2019-11-26 |
4 |
S |
$68.73 |
$1,097,951 |
D/D |
(15,974) |
16,478 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2019-11-26 |
4 |
OE |
$18.32 |
$312,438 |
D/D |
15,974 |
32,452 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-11-26 |
4 |
S |
$68.36 |
$452,885 |
D/D |
(6,621) |
9,304 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-11-25 |
4 |
S |
$69.18 |
$22,969 |
D/D |
(332) |
15,925 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-11-20 |
4 |
D |
$65.82 |
$16,598,027 |
D/D |
(252,173) |
427,013 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-11-20 |
4 |
OE |
$15.19 |
$8,470,451 |
D/D |
377,744 |
679,186 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2019-10-12 |
4 |
D |
$57.65 |
$390,060 |
D/D |
(6,766) |
16,478 |
|
- |
|
Russell Edward Keith |
SVP, Business Development |
|
2019-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,646 |
23,244 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2019-09-23 |
4 |
S |
$62.60 |
$1,836,041 |
D/D |
(29,328) |
19,459 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2019-09-23 |
4 |
OE |
$15.40 |
$451,651 |
D/D |
29,328 |
48,787 |
|
- |
|
799 Records found
|
|
Page 11 of 32 |
|
|